Skip to main content
OpenTrials
Completed

NCT Number: NCT02020187

Aerobic Training in Patients With Congenital Myopathies

Congenital myopathies are clinical and genetic heterogeneous disorders characterized by skeletal muscle weakness. Most patients experience muscle weakness and fatigue throughout their life. However, progression of symptoms is rare. There are no specific treatments for congenital myopathies. Training has been shown to benefit several other muscle diseases with weakness, but the defect in congenital myopathies involves contractile proteins of the sarcomere, why the effect of training is uncertain in these conditions. The investigators will therefore investigate the effect cycle-ergometer training for 30 minutes, three times weakly, for ten weeks in 15 patients with congenital myopathy. Another 5-10 congenital myopathy patients, who do not train, will serve as controls for the trained patients. The study starts and ends with a test day, where efficacy based on VO2max, performance in functional tests and a questionnaire will be assessed.

Completed

Looking for future studies?

Notify Me

Key information

About this study

10 weeks of cycle-ergometer training at home. Intensity at 70% of maximal VO2,max.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Danish patients with gene verified congenital myopathy

Exclusion criteria

  • Patients who are to week to train at a cycle-ergometer for 10 weeks
  • Patients who have other health issues, which can disturb the interpretation of the efficacy

Treatment and study plan

Exercise on a cycle-ergometer

Other

Home training on an ergometer-cycle 30 minutes every other day or at least three times a week. Subject will exercise in a pulse interval corresponding to 70% of their maximal VO2.

Primary outcomes

  1. Efficacy based on VO2,max

    Time frame: 10 weeks

    Difference in VO2,max from baseline to end of intervention.

Secondary outcomes

  1. Level of Creatine Kinase

    Time frame: 10 weeks

    Marker for exercise-induced muscle damage. Taken week 0, 3 and 10.

  2. Intensity in maximal Watt

    Time frame: 10 weeks

    Changes in the maximal intensity (watt) from baseline VO2,max test to after the intervention.

  3. 6 minute walk test

    Time frame: 10 weeks

    Changes in the walking distance from baseline to after the intervention.

  4. SF-36 questionnaire

    Time frame: 10 weeks

    Changes in SF-36 questionnaire from baseline to after the intervention.

  5. A timed five-repetitions-sit-to-stand-test

    Time frame: 10 weeks

    Changes in time from baseline to after the intervention.

  6. A timed 14-step-stair-test

    Time frame: 10 weeks

    Changes in time from baseline to after the intervention.

  7. Dynamometry

    Time frame: 10 weeks

    Changes in external force production from baseline to after the intervention. Dynamometry measurements are done at hip flexion, dorsal foot flexion, plantar foot flexion, knee flexion, knee extension and elbow flexion.

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Dec 24, 2013
Registry last updated
May 12, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.